تحميل...
Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes
BACKGROUND: Immune checkpoint inhibitors (ICPi) are a novel and promising anti-cancer therapy. There are limited data on the incidence, risk factors and outcomes of acute kidney injury (AKI) in patients receiving ICPi. METHODS: We conducted a cohort study of patients receiving ICPi at our center bet...
محفوظ في:
| الحاوية / القاعدة: | J Immunother Cancer |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMJ Publishing Group
2020
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7326260/ https://ncbi.nlm.nih.gov/pubmed/32601079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000467 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|